HHealth Read More New nanoparticle therapy overcomes T cell exhaustion in solid tumorsMarch 18, 2026 Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one…
TTechnology Read More New insights highlight multifaceted roles of CD4+ T cells in tumor immunityMarch 14, 2026 For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor…
HHealth Read More Study finds cockroach allergy often driven by shared proteins across arthropodsMarch 13, 2026 A new molecular analysis reveals that many patients labeled as cockroach-allergic may actually be reacting to shared proteins…
TTechnology Read More Remote-controlled CAR T cells offer safer cancer therapyFebruary 20, 2026 Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells…
HHealth Read More Preoperative combination treatment shows promise for some patients with pancreatic cancerFebruary 17, 2026 A new UCLA investigator-initiated study sponsored by the UCLA Health Jonsson Comprehensive Cancer Center has found that adding immunotherapy to…
HHealth Read More Chronic inflammation shapes cancer progression and immunotherapy responseFebruary 16, 2026 Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs,…
HHealth Read More Rising lung cancer in never smokers demands urgent research focusFebruary 12, 2026 Lung cancer patients who have never smoked make up a significant and growing share of global lung cancer…
HHealth Read More Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical studyFebruary 12, 2026 A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the possibility that engineered immune…
HHealth Read More MHC class II marks stronger immune response and longer survival in ovarian cancerFebruary 10, 2026 A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond…
HHealth Read More Stage IV lung cancer survivor: ‘Go straight to MD Anderson’ February 3, 2026 By the time I was diagnosed with stage IV lung cancer in the fall of 2024, it had spread all over my body. Scans showed the cancer was in…
HHealth Read More Regulating microglial phagocytosis through immunotherapy could slow Parkinson’s disease progressionFebruary 2, 2026 By analyzing tissue from patients with Parkinson’s disease, and animal and cellular models of the disease, a research…
HHealth Read More Treating desmoplastic melanoma with immunotherapy before surgery can shrink or eliminate tumorsJanuary 29, 2026 New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and…